This helps convert the amino acid metabolite homocysteine into amino acid methionine, consistently helping recycle homocysteine Folic acid and vitamin B12 (Methyl CPG + Methyl B12) 0.2-0.8 mg as folic acid or 5-methylfolate (5-MTHF) per day, minimum 12 weeks for greatest benefit and maintenance for up to ~5 years, with optional 0.4-1.0 mg vitamin B12 for improved efficacy in patients with elevated homocysteine (3)(5)(6)(7)(10)(12)(15)(16)(21)(23)(34)(37)(38) Folic acid provided primary effect on homocysteine reductions ranging between ~13-30% (3)(4)(5)(6)(7)(10)(12)(15)(16)(21)(22)(23)(26)(32)(34)(40) Proportions of reductions in homocysteine were highly dependent on greater baseline homocysteine and lower baseline folate levels (5)(15)(16)(29)(37) Higher folic acid doses ranging between 5-60 mg per day were safely used, but did not reduce homocysteine further than ingestion of 0.8 mg (16)(22)(29)(32)(40) Most human evidence did not support greater folate bioavailability or efficacy in reducing homocysteine by 5-MTHF over folic acid, but it may provide extended retention of benefit upon discontinuation in patients with poor methylation capacity (2) Vitamin B12 produced additional ~7% reduction in homocysteine (4)(5)(15)(16)(21) Individual trials showed benefit of adding vitamin B6 for further reductions in homocysteine, however this was not supported in meta-analyses (3)(5)(15)(16)(23)(34) Males may have required higher folic acid dose ranges than women (6) NAC (Acetylcysteine) Precursor to Glutathione, the master antioxidant in the body.N-acetylcysteine (NAC) 600 mg, 2-3 times per day, for 2-8 weeks (14)(24)(36)(41) Reduced total homocysteine by 12-45% in healthy patients or patients at increased risk for CVD (9)(14)(24)(36)(39) Oral formulations reduced total homocysteine in patients with end-stage renal disease by 21-25%, while intravenous formulations further reduce homocysteine during hemodialysis by ~90% (24)(27)(31) Reduced SBP (~7.1 mmHg) and DBP (~3.3 mmHg) in hyperlipidemic men and SBP (~3.2 mmHg) in normolipidemic men

Take extra care when measuring out the volume of the dose as this can affect how well the peptide functions in your body

Potential Benefits of AOD-9604 Targeted Fat Reduction Directly stimulates the breakdown of stored fat in adipose tissue, particularly in stubborn areas resistant to diet and exercise Inhibited Fat Formation Prevents the creation of new fat cells, supporting long-term body composition improvements beyond initial fat loss No Blood Sugar Impact Does not affect glucose metabolism or insulin sensitivity, making it safe for patients concerned about metabolic disruption No IGF-1 Stimulation Avoids the cell proliferation effects associated with full HGH therapy while retaining the fat-specific benefits Improved Body Composition Helps shift the ratio of fat to lean tissue for a more defined, healthier physique Complementary to Diet and Exercise Enhances results from nutrition and training programs by targeting fat at the cellular level Potential Joint Support Emerging research suggests AOD-9604 may support cartilage health and repair Well-Tolerated Safety Profile Decades of research support AOD-9604's safety for fat reduction applications without significant adverse effects What Is AOD-9604 For

TB-500: Practical Comparison for Patients What Recovery Peptides Cannot Replace Recovery peptides are sometimes discussed as if they can replace the fundamentals